JCEM:男性和女性老龄化、心血管风险与SHBG水平

2021-07-03 MedSci原创 MedSci原创

SHBG水平随年龄增长存在明显的性别差异。该研究的结果强调了考虑SHBG水平与年龄相关变化的重要性,以避免在评估与SHBG相关的心血管风险时出现有争议的结果。

既往的研究报告了男性和女性性激素结合球蛋白(SHBG)与血管疾病之间关联结果并不一致。尽管有人提出SHBG水平随年龄增长而变化,但SHBG与年龄和心血管风险的确切趋势以及这些变化的潜在机制尚未明确。

近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章,研究人员使用来自基于人群的大型队列研究的3264名男性和女性的数据,可视化了血清SHBG水平跨年龄的分布情况。其次,研究人员计算了心血管风险因素总分并调查了危险因素总分类别中的平均SHBG水平,并按年龄进行分层。

研究人员使用线性回归模型探究血清SHBG水平与年龄和SHBG的潜在调节因素之间的关联,包括体重指数(BMI)、空腹胰岛素、性类固醇、甲状腺素和甘油三酯。

在男性中,SHBG水平随年龄呈线性增加,在女性中观察到U型关联。心血管危险因素较多的参与者SHBG水平较低。当按年龄分层时,年龄较大的参与者SHBG水平较高。在包括男性总睾酮和甘油三酯水平以及女性总睾酮、甘油三酯、BMI和空腹胰岛素在内的多变量模型中,分别解释了46.2%和31.8%的SHBG水平差异。

由此可见,SHBG水平随年龄增长存在明显的性别差异。该研究的结果强调了考虑SHBG水平与年龄相关变化的重要性,以避免在评估与SHBG相关的心血管风险时出现有争议的结果。

原始出处:

Elif Aribas.et al.Aging, cardiovascular risk and SHBG levels in men and women from the general population.JCEM.2021.https://doi.org/10.1210/clinem/dgab470

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-03-02 smallant2015
  3. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-02-28 achengzhao
  4. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-05 zhty5343
  6. [GetPortalCommentsPageByObjectIdResponse(id=2082559, encodeId=42cf208255943, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Wed Jul 07 03:22:32 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778071, encodeId=c3481e78071d2, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Wed Mar 02 01:22:32 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063453, encodeId=41842063453bd, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Mon Feb 28 03:22:32 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344701, encodeId=344c1344e01af, content=<a href='/topic/show?id=225d8029411' target=_blank style='color:#2F92EE;'>#老龄化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80294, encryptionId=225d8029411, topicName=老龄化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5742500212, createdName=12498f17m66暂无昵称, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602825, encodeId=536816028250c, content=<a href='/topic/show?id=dea516245a3' target=_blank style='color:#2F92EE;'>#SHBG#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16245, encryptionId=dea516245a3, topicName=SHBG)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a2b18942585, createdName=zhty5343, createdTime=Mon Jul 05 00:22:32 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996262, encodeId=0e279962623a, content=性激素结合蛋白也是值得我们研究的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cdb2944259, createdName=63766754, createdTime=Sun Jul 04 23:29:24 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 63766754

    性激素结合蛋白也是值得我们研究的

    0

相关资讯

JAMA:经济增长率与中年人群心血管死亡风险呈负相关

经济发展水平与中年人群心血管死亡风险相关,地区经济水平发展快速,中年人群心血管死亡率相对较低

Heart:2型糖尿病患者心血管和肾脏预后的预测模型

多种2型糖尿病患者心血管和肾脏预后的预测模型孰优孰劣?

PLoS Med:肥胖和营养不良与心脏重构和心血管结局的相关性

肥胖是心血管疾病和心力衰竭(HF)众所周知的风险因素,与普通人群的不良心室重构相关。营养状况如何改变肥胖与相关健康预后之间的关系尚未完全明确。该研究旨在调查肥胖和营养状况与普通社区人群的临床特征、超声

JACC:系统性红斑狼疮患者的长期心血管结局风险和预后

系统性红斑狼疮患者的多种心血管结局的长期风险较高且预后不良~

Alzheimer Dementia :中年时控制血压可降低痴呆风险

中年时控制血压可降低痴呆风险

JAHA:2型糖尿病低风险人群他汀类药物一级预防依从性与心血管风险和死亡相关

该研究支持使用在低风险T2D患者中,他汀类药物作为心血管疾病或死亡的一级预防药物,在老年和依从性患者中效果最佳。